Form DEFA14A Zoetis Inc.

Go back to Form DEFA14A Zoetis Inc.

Zoetis (ZTS) stock drops following WSJ report on pet arthritis drugs

April 12, 2024 12:00 PM EDT

Zoetis (NYSE: ZTS) stock dropped more than 7% Friday after a report from The Wall Street Journal said there were various adverse events linked to the pet health companys osteoarthritis pain drugs Librela and Solensia.

The publication stated that the FDA received over 3,800... More